Characteristics and Outcomes of Squamous Cell Carcinoma and Other Cutaneous Malignancies in Epidermolysis Bullosa: A Systematic Review

医学 大疱性表皮松解症 皮肤病科 基底细胞 病理
作者
Patrick Jinhyung Kim,Abrahim Abduelmula,Jenna Mistry,Asfandyar Mufti,Ronald Gary Sibbald
出处
期刊:Advances in Skin & Wound Care [Lippincott Williams & Wilkins]
卷期号:36 (9): 486-494 被引量:4
标识
DOI:10.1097/01.asw.0000926608.29276.e9
摘要

OBJECTIVE: To identify cases and summarize outcomes of cutaneous malignancies in patients with epidermolysis bullosa (EB). DATA SOURCES: MEDLINE and EMBASE databases were searched on February 8, 2022. STUDY SELECTION: Original observational or experimental studies with cases of cutaneous malignancy in patients with inherited EB were included. DATA EXTRACTION: Data were extracted by two reviewers in duplicate. DATA SYNTHESIS: A total of 87 articles with 367 patients were included in this systematic review. Squamous cell carcinomas were the most common malignancy (94.3%) with a median survival of 60 months. The presence of metastasis was investigated at diagnosis in 77 patients; 18.8% of patients had detectable metastasis. Patients with squamous cell carcinoma with metastasis at diagnosis had significantly shorter median survival (16.8 months) than those without (72 months; P = .027). The remission rate was 47.6%. At the end of follow-up, 15.1% were alive with disease, and 41.6% were deceased. Other malignancies included malignant melanoma and basal cell carcinoma. The most common initial modes of management were excisions (71.9%) and amputations (17.6%). Other modes included chemotherapy (4.6%), radiation (3.9%), and no treatment (2.6%). The overall rate of recurrence or new lesions was 38.8%, with a median time of 16 months to recurrence or new lesions. Immediate recurrence was lowest following amputation (4.3%). There were no statistically significant differences in median survival among initial excision, amputation, and all other modes combined ( P = .30). CONCLUSIONS: Squamous cell carcinomas in patients with EB have a high likelihood of metastasis and mortality. Surgical excision is the most common intervention. There are no significant differences in survival among different initial management options. There is a need for research that documents and monitors outcomes of the treatment options.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
玉玉玉米发布了新的文献求助10
刚刚
开朗含海发布了新的文献求助10
1秒前
风语村发布了新的文献求助10
1秒前
小姜完成签到 ,获得积分10
1秒前
taipingyang发布了新的文献求助10
2秒前
YangyangShi完成签到 ,获得积分10
2秒前
传奇3的应助被科研通管家采纳,获得10
3秒前
clevenx完成签到,获得积分10
3秒前
李爱国的应助被科研通管家采纳,获得10
3秒前
赘婿的应助被科研通管家采纳,获得10
3秒前
Owen的应助被科研通管家采纳,获得10
3秒前
小蘑菇的应助被科研通管家采纳,获得10
3秒前
君为臣纲的应助被科研通管家采纳,获得10
3秒前
无花果的应助被科研通管家采纳,获得10
3秒前
无花果的应助被科研通管家采纳,获得10
3秒前
小马甲的应助被科研通管家采纳,获得10
4秒前
Orange的应助被科研通管家采纳,获得10
4秒前
xy的应助被科研通管家采纳,获得30
4秒前
昭君出川完成签到,获得积分10
4秒前
4秒前
酷波er的应助被科研通管家采纳,获得10
4秒前
彭于晏的应助被科研通管家采纳,获得10
4秒前
4秒前
4秒前
在水一方的应助被科研通管家采纳,获得10
5秒前
yy完成签到,获得积分10
5秒前
CipherSage的应助被科研通管家采纳,获得10
5秒前
5秒前
瀚子完成签到,获得积分10
5秒前
耍酷的小刺猬完成签到 ,获得积分10
5秒前
6秒前
6秒前
石头糖巧克力完成签到,获得积分20
6秒前
顺风顺水的薇容完成签到,获得积分10
7秒前
xinyuanjia发布了新的文献求助10
7秒前
慈祥的人达完成签到,获得积分20
9秒前
9秒前
10秒前
CodeCraft的应助被MMLi采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264